Institutional Ownership Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the institutional ownership of Arcutis Biotherapeutics, Inc. (ARQT). We have compiled data on the 240 institutions that hold shares in the stock, with a total of 129 Million shares, which have been reported (via 13F filing form) to have a value of $1.89 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Suvretta Capital Management, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
11,535,582
shares
|
$170 Million
5.56% of portfolio
|
Q2 2025
Added 0.99%
|
|
Jennison Associates LLC
|
Aug 01, 2025 Q2 2025 |
11,109,405
shares
|
$164 Million
0.09% of portfolio
|
Q2 2025
Reduced 2.21%
|
|
Rubric Capital Management LP
New York, NY |
Aug 14, 2025 Q2 2025 |
10,749,457
shares
|
$158 Million
3.47% of portfolio
|
Q2 2025
Reduced 1.98%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
9,874,511
shares
|
$146 Million
7.3% of portfolio
|
Q2 2025
Added 12.4%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
8,622,618
shares
|
$127 Million
0.0% of portfolio
|
Q2 2024
Added 29.49%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
7,049,099
shares
|
$104 Million
0.0% of portfolio
|
Q2 2025
Added 3.39%
|
|
Polar Capital Holdings PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
5,006,475
shares
|
$73.8 Million
0.4% of portfolio
|
Q2 2025
Reduced 25.35%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
4,526,937
shares
|
$66.7 Million
0.0% of portfolio
|
Q2 2025
Added 1.18%
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
4,314,530
shares
|
$63.6 Million
0.0% of portfolio
|
Q2 2025
Added 12.4%
|
|
Gilder Gagnon Howe & CO LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
4,155,763
shares
|
$61.3 Million
0.69% of portfolio
|
Q2 2025
Added 1.46%
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
2,937,939
shares
|
$43.3 Million
0.01% of portfolio
|
Q2 2025
Added 0.61%
|
|
Franklin Resources Inc
San Mateo, CA |
Aug 12, 2025 Q2 2025 |
2,732,777
shares
|
$40.3 Million
0.01% of portfolio
|
Q2 2025
Reduced 1.05%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
2,582,567
shares
|
$38.1 Million
0.0% of portfolio
|
Q2 2025
Added 1.4%
|
|
Janus Henderson Group PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
2,263,960
shares
|
$33.4 Million
0.02% of portfolio
|
Q2 2025
Added 4204.11%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Aug 14, 2025 Q2 2025 |
2,163,001
shares
|
$31.9 Million
0.02% of portfolio
|
Q2 2025
Added 8.72%
|
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
Aug 13, 2025 Q2 2025 |
2,120,508
shares
|
$31.3 Million
28.07% of portfolio
|
Q3 2024
Added 3.89%
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
May 14, 2025 Q1 2025 |
1,988,389
shares
|
$29.3 Million
0.06% of portfolio
|
Q1 2025
Reduced 16.25%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
1,890,246
shares
|
$27.9 Million
0.0% of portfolio
|
Q2 2025
Added 71.31%
|
|
American Century Companies Inc
Kansas City, MO |
Aug 12, 2025 Q2 2025 |
1,724,307
shares
|
$25.4 Million
0.01% of portfolio
|
Q2 2025
Added 4.35%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Aug 14, 2025 Q2 2025 |
1,485,425
shares
|
$21.9 Million
0.05% of portfolio
|
Q2 2025
Added 78.86%
|
|
Gw&K Investment Management, LLC
Boston, MA |
Aug 11, 2025 Q2 2025 |
1,378,432
shares
|
$20.3 Million
0.17% of portfolio
|
Q2 2025
Reduced 8.85%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,327,029
shares
|
$19.6 Million
0.02% of portfolio
|
Q2 2023
Reduced 19.87%
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
1,202,513
shares
|
$17.7 Million
0.0% of portfolio
|
Q2 2025
Added 133.52%
|
|
Driehaus Capital Management LLC
Chicago, IL |
Aug 14, 2025 Q2 2025 |
1,085,954
shares
|
$16 Million
0.15% of portfolio
|
Q2 2025
Reduced 0.62%
|
|
Cormorant Asset Management, LP
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,000,000
shares
|
$14.7 Million
1.41% of portfolio
|
Q2 2025
Reduced 25.93%
|